Usca Ria LLC raised its holdings in UnitedHealth Group Inc (NYSE:UNH) by 58.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,127 shares of the healthcare conglomerate’s stock after purchasing an additional 3,358 shares during the quarter. Usca Ria LLC’s holdings in UnitedHealth Group were worth $2,428,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. FMR LLC grew its position in UnitedHealth Group by 5.1% during the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after buying an additional 2,981,233 shares during the period. Vontobel Asset Management Inc. purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $404,980,000. Bank of Montreal Can purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $381,555,000. Janus Henderson Group PLC lifted its stake in shares of UnitedHealth Group by 61.7% during the second quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock valued at $864,869,000 after buying an additional 1,345,083 shares during the period. Finally, Chevy Chase Trust Holdings Inc. purchased a new position in shares of UnitedHealth Group during the second quarter valued at approximately $248,898,000. Institutional investors own 85.57% of the company’s stock.
UNH has been the topic of several recent analyst reports. Cantor Fitzgerald reissued a “buy” rating and set a $300.00 price objective on shares of UnitedHealth Group in a research note on Thursday, August 9th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Citigroup downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective on the stock. in a research note on Monday, September 10th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 11th. Finally, Cowen began coverage on shares of UnitedHealth Group in a research note on Monday, September 17th. They set an “outperform” rating and a $308.00 price target on the stock. Two research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $292.48.
NYSE UNH traded down $7.78 during trading hours on Wednesday, reaching $278.55. 4,634,927 shares of the company traded hands, compared to its average volume of 3,474,487. UnitedHealth Group Inc has a 12 month low of $208.48 and a 12 month high of $287.94. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69. The company has a market capitalization of $270.68 billion, a price-to-earnings ratio of 27.66, a price-to-earnings-growth ratio of 1.65 and a beta of 0.76.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. During the same period last year, the firm posted $2.66 EPS. The company’s revenue for the quarter was up 12.4% on a year-over-year basis. As a group, analysts anticipate that UnitedHealth Group Inc will post 12.82 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be given a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 163 shares of the firm’s stock in a transaction dated Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The disclosure for this sale can be found here. Over the last quarter, insiders sold 60,428 shares of company stock worth $16,232,134. 0.87% of the stock is currently owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is the NASDAQ?